動物用医薬品市場：医薬品タイプ、動物タイプ、投与経路別-2025-2030年世界予測

動物用医薬品市場は、2023年に230億3,000万米ドルと評価され、2024年には243億9,000万米ドルに達すると予測され、CAGR 5.98％で成長し、2030年には346億米ドルに達すると予測されています。

動物用医薬品市場には、動物の病気の治療、予防、診断のために設計された医薬品が幅広く含まれています。この市場は、畜産物に対する需要の増加やペット飼育の隆盛により、効果的な動物ヘルスケアソリューションが必要不可欠となっています。動物用医薬品の用途は、ペットの慢性・急性疾患の治療から、家畜の成長や疾病管理の改善まで多岐にわたる。最終用途の主な産業には、動物病院、診療所、農場、小売店などが含まれ、国内および商業的な動物ケア部門における幅広い用途を反映しています。

この市場の主な成長要因としては、人獣共通感染症の増加、動物ヘルスケア技術の進歩、動物の健康に対する意識の高まりなどが挙げられます。また、獣医療に対する政府の取り組みや資金提供の増加も、市場の拡大をさらに後押ししています。しかし、厳しい規制要件、研究開発コストの高さ、薬剤の潜在的な副作用といった課題は、成長を阻害する可能性があります。医薬品のオンライン販売や遠隔医療サービスの拡大により、ペットの飼い主や家畜の管理者へのアクセシビリティと利便性が向上することは、注目すべきビジネスチャンスです。企業はまた、ゲノムとバイオテクノロジーの技術的進歩に後押しされ、個別化された動物医療における未開拓の可能性を探ることもできます。アジア太平洋とラテンアメリカの新興市場は、ペット飼育と農業活動の増加により、有望な拡大機会を提供しています。

持続的な成長のためには、製剤、送達システムの革新、動物用医薬品の環境負荷低減への注力が最も重要です。AIとデータ分析統合のためのテクノロジー企業とのコラボレーションは、精密医療を推進し、治療成果を高めることができます。楽観的な成長見通しとは裏腹に、偽造医薬品や地域によって異なる規制といった現在進行中の課題は、市場の進展を妨げる可能性があります。費用対効果が高く、広く適用可能なソリューションの開拓を重視することで、企業はこれらの課題を軽減し、市場での確固たる地位と動物の健康状態の改善を確保することができます。イノベーションと規制遵守のバランスを取ることで、企業は進化する市場情勢を効果的に乗り切ることができます。

市場力学：急速に進化する動物用医薬品市場の主要な市場洞察の解明

動物用医薬品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 経済圏におけるペット飼育と家畜人口の増加
  • ペット保険の普及
  • 様々な病気の治療に使用できる動物用医薬品の増加
• 市場抑制要因
  • 高いペットケア費用
• 市場機会
  • 新しい高度な動物用医薬品のイントロダクション
  • 動物ヘルスケア支出の拡大
• 市場の課題
  • 生産に伴う複雑さ

ポーターの5つの力動物用医薬品市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用医薬品市場における外部からの影響の把握

外部マクロ環境要因は、動物用医薬品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用医薬品市場における競合情勢の把握

動物用医薬品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用医薬品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用医薬品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用医薬品市場における成功への道筋を描く

動物用医薬品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 経済におけるペット飼育数と家畜頭数の増加
    • ペット保険の普及率の上昇
    • さまざまな病気の治療に使用できる数多くの獣医用医薬品の入手可能性の向上
  • 抑制要因
    • ペットのケア費用が高い
  • 機会
    • 新しい先進的な獣医薬のイントロダクション
    • 動物ヘルスケア費の拡大
  • 課題
    • 生産に伴う複雑さ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用医薬品市場薬の種類別

• 抗感染
• 抗炎症
• 寄生虫駆除剤

第7章 動物用医薬品市場動物の種類別

• ペット
• 家畜

第8章 動物用医薬品市場：投与経路別

• オーラル
• 非経口
• 話題

第9章 南北アメリカの動物用医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の動物用医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの動物用医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Biogenesis Bago SA
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Evonik Industries AG
• Hester Biosciences Limited
• Huvepharma, Inc.
• Merck & Co., Inc.
• Neogen Corporation
• Nutreco N.V.
• Perrigo Company PLC
• Vetoquinol S.A.
• Virbac S.A.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY DRUG MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY DRUG MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY DRUG MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY DRUG MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY DRUG MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY DRUG MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY DRUG MARKET SIZE, BY PARASITICIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY DRUG MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 145. VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, 2023

The Veterinary Drug Market was valued at USD 23.03 billion in 2023, expected to reach USD 24.39 billion in 2024, and is projected to grow at a CAGR of 5.98%, to USD 34.60 billion by 2030.

The veterinary drug market encompasses a wide range of pharmaceuticals designed for the treatment, prevention, and diagnosis of diseases in animals. This market is essential due to the increasing demand for livestock products and the heightened prominence of pet ownership, necessitating effective animal healthcare solutions. Applications of veterinary drugs span from treating chronic and acute conditions in pets to improving livestock growth and disease management. End-use industries include veterinary hospitals, clinics, farms, and retail settings, reflecting the broad scope of application across domestic and commercial animal care sectors.

Key growth factors in this market include rising zoonotic diseases, advancements in animal healthcare technologies, and increased awareness about animal health. Also, increased government initiatives and funding for veterinary healthcare further bolster market expansion. However, challenges such as stringent regulatory requirements, high R&D costs, and potential side effects of drugs may impede growth. Noteworthy opportunities arise in the expansion of online pharmaceutical retailing and telemedicine services, offering increased accessibility and convenience to pet owners and livestock managers. Companies can also explore the untapped potential in personalized veterinary medicine, driven by technological advances in genomics and biotechnology. Emerging markets in Asia Pacific and Latin America offer promising expansion opportunities due to rising pet adoption and agricultural activities.

For sustained growth, innovation in formulations, delivery systems, and a focus on reducing the environmental impact of veterinary pharmaceuticals are paramount. Collaboration with technology firms for AI and data analytics integration can drive precision medicine, enhancing treatment outcomes. Despite the optimistic growth outlook, ongoing challenges such as counterfeit drugs and variable regulations across regions could hinder market progression. Emphasizing the development of cost-effective and widely applicable solutions, companies can alleviate these challenges, ensuring robust market position and improved animal health outcomes. By balancing innovation with regulatory compliance, businesses can effectively navigate the evolving landscape of the veterinary drug market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Drug Market

The Veterinary Drug Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing pet ownership and livestock population in economies
  • Growing penetration of pet insurance
  • Growing availability of numerous veterinary drugs for treatment of several diseases
• Market Restraints
  • High pet care cost
• Market Opportunities
  • Introduction of new and advanced veterinary drugs
  • Expansion of animal healthcare expenditure
• Market Challenges
  • Complexities associated with the production

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Drug Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Drug Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Drug Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Drug Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Drug Market

A detailed market share analysis in the Veterinary Drug Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Drug Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Drug Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Drug Market

A strategic analysis of the Veterinary Drug Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Drug Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Huvepharma, Inc., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Perrigo Company PLC, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Drug Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across Anti-Infective, Anti-Inflammatory, and Parasiticide.
• Based on Animal Type, market is studied across Companion Animal and Livestock Animal.
• Based on Route of Administration, market is studied across Oral, Parenteral, and Topical.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing pet ownership and livestock population in economies
    • 5.1.1.2. Growing penetration of pet insurance
    • 5.1.1.3. Growing availability of numerous veterinary drugs for treatment of several diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High pet care cost
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of new and advanced veterinary drugs
    • 5.1.3.2. Expansion of animal healthcare expenditure
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities associated with the production
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Drug Market, by Drug Type

• 6.1. Introduction
• 6.2. Anti-Infective
• 6.3. Anti-Inflammatory
• 6.4. Parasiticide

7. Veterinary Drug Market, by Animal Type

• 7.1. Introduction
• 7.2. Companion Animal
• 7.3. Livestock Animal

8. Veterinary Drug Market, by Route of Administration

• 8.1. Introduction
• 8.2. Oral
• 8.3. Parenteral
• 8.4. Topical

9. Americas Veterinary Drug Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Veterinary Drug Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary Drug Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Biogenesis Bago SA
• 2. Boehringer Ingelheim International GmbH
• 3. Ceva Sante Animale
• 4. Dechra Pharmaceuticals PLC
• 5. Elanco Animal Health Incorporated
• 6. Evonik Industries AG
• 7. Hester Biosciences Limited
• 8. Huvepharma, Inc.
• 9. Merck & Co., Inc.
• 10. Neogen Corporation
• 11. Nutreco N.V.
• 12. Perrigo Company PLC
• 13. Vetoquinol S.A.
• 14. Virbac S.A.
• 15. Zoetis Inc.